See leaflet
Cosmegen®
dactinomycin
Indications
- Wilms’ tumor.
- Rhabdomyosarcoma.
- Ewing’s sarcoma.
- Metastatic, nonseminomatous testicular cancer.
- Trophoblastic neoplasia.
- As a component of regional perfusion, is indicated for the palliative and/or adjunctive treatment of locally recurrent or locoregional solid malignancies.
Presentations
- 500 mcg vial x 1
- 500 mcg vial x 1